EXHIBIT 10.22 SUBSCRIPTION AND STOCK PURCHASE AGREEMENT THIS SUBSCRIPTION AND STOCK PURCHASE AGREEMENT, dated as of December 18, 2003 (this "Agreement"), is entered into by and between EMPIRE FINANCIAL HOLDING COMPANY, a Florida corporation (the...Subscription and Stock Purchase Agreement • January 2nd, 2004 • Empire Financial Holding Co • Security brokers, dealers & flotation companies • Florida
SUBSCRIPTION AND STOCK PURCHASE AGREEMENTSubscription and Stock Purchase Agreement • November 24th, 2009 • Generac Holdings Inc. • Motors & generators • Delaware
This SUBSCRIPTION AND STOCK PURCHASE AGREEMENT is made as of September 2, 2009 (the “Agreement”), by and between GPS CCMP Acquisition Corp., a Delaware corporation (the “Company”), and Ed Leblanc (the “Purchaser”).
SUBSCRIPTION AND STOCK PURCHASE AGREEMENT OF IDEAL POWER CONVERTERS, INC.Subscription and Stock Purchase Agreement • September 18th, 2013 • Ideal Power Inc. • Electrical industrial apparatus
NOTICE: THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SUCH ACT AND QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS, OR UNLESS THE CORPORATION HAS RECEIVED AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED.
SUBSCRIPTION AND STOCK PURCHASE AGREEMENT COMMON STOCK OF MIMEDX GROUP, INC.Subscription and Stock Purchase Agreement • January 7th, 2010 • Mimedx Group, Inc. • Surgical & medical instruments & apparatus • Florida
SUBSCRIPTION AND STOCK PURCHASE AGREEMENT by and among ONCOCYTE CORPORATION, as Buyer, ENCORE CLINICAL, INC., as Parent, and RAZOR GENOMICS INC., as the Company, Dated as of September 4, 2019Subscription and Stock Purchase Agreement • October 3rd, 2019 • OncoCyte Corp • In vitro & in vivo diagnostic substances • Delaware
This SUBSCRIPTION AND STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of September 4, 2019 by and among (i) OncoCyte Corporation, a California corporation (“Buyer”), (ii) Encore Clinical, Inc., a Delaware corporation (“Parent”), and (iii) Razor Genomics Inc., a Delaware corporation (the “Company”). Buyer, Parent and the Company are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.
SUBSCRIPTION AND STOCK PURCHASE AGREEMENTSubscription and Stock Purchase Agreement • June 30th, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
THIS SUBSCRIPTION AND STOCK PURCHASE AGREEMENT (this “Agreement”), is made this [l] day of [l], 2020 by and between MYOS Corp., a Delaware corporation with a principal place of business at 45 Horsehill Road, Suite 106, Cedar Knolls, NJ 07927 (the “Corporation”), and MYOS RENS Technology, Inc., a Nevada corporation with a principal place of business at 45 Horsehill Road, Suite 106, Cedar Knolls, NJ 07927 (the “Purchaser”). The Corporation and Purchaser are each also referred to herein as a “Party” and together as the “Parties.”
SUBSCRIPTION AND STOCK PURCHASE AGREEMENTSubscription and Stock Purchase Agreement • November 24th, 2009 • Generac Holdings Inc. • Motors & generators • Delaware
This SUBSCRIPTION AND STOCK PURCHASE AGREEMENT is made as of November 25, 2008 (the “Agreement”), by and among GPS CCMP Acquisition Corp., a Delaware corporation (the “Company”), CCMP Capital Investors II, L.P. (“CCMP”) and CCMP Capital Investors (Cayman) II, L.P. (“Cayman” and together with CCMP, the “Purchasers”).
ARTICLE ISubscription and Stock Purchase Agreement • January 9th, 2003 • National Waterworks Inc • Delaware
